SGL has received grants from Gilead Sciences, Abbott Diagnostics, and Sysmex; consulting fees for participation on advisory boards from Janssen, Roche, Fibronostics, Gilead, GSK, Sysmex, Assembly, Arbutus, and Grifols; and payments for participation in speakers' bureau from Gilead Sciences, Janssen, Roche, Sysmex, and GSK. SGL is an Asia Pacific regional advisor to AASLD; an ICE-HBV governing board member; an HBV Forum board member; a scientific advisory board member of ANRS; and chairman of Singapore Hepatology Conference and Science of HBV Cure Conference, all of which are unpaid.